Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
13.39
+0.59 (4.61%)
Dec 3, 2025, 3:29 PM EST - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $415.98 million as of December 3, 2025. Its market cap has increased by 235.30% in one year.
Market Cap
415.98M
Enterprise Value
311.64M
1-Year Change
235.30%
Ranking
Category
Stock Price
$13.39
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $415.98M, a decrease of -21.32%. That is a compound annual growth rate of -12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 397.65M | 248.56% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |